Palisade Bio (PALI) Change in Intangibles (2010 - 2017)
Palisade Bio (PALI) reported Change in Intangibles of -$1129.0 for Q3 2017, down 103.44% quarter-over-quarter from $32843.0 in Q4 2016.
Palisade Bio (PALI) Change in Intangibles (2010 - 2017) Analysis & Trends
Palisade Bio (PALI) has 8 years of Change in Intangibles data on file, last reported at -$1129.0 in Q3 2017.
- Change in Intangibles for Q3 2017 came in at -$1129.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $31714.0 (down 49.68% YoY), and the FY2017 annual result was $82645.0, up 31.13% from the prior year.
- Change in Intangibles declined to -$1129.0 in Q3 2017 per PALI's latest filing, from $32843.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $137054.0 in Q2 2013 and troughed at -$8823.0 in Q3 2015.
- A 5-year average of $55584.5 and a median of $48801.0 in 2014 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2015 and 2016: Change in Intangibles sank 114.58% in 2015, then surged 457.13% in 2016.
- A 5-year view of Change in Intangibles shows it stood at $85905.0 in 2013, then plunged by 53.07% to $40319.0 in 2014, then tumbled by 85.38% to $5895.0 in 2015, then surged by 457.13% to $32843.0 in 2016, then slumped by 103.44% to -$1129.0 in 2017.
- Business Quant data shows PALI's Change in Intangibles at -$1129.0 in Q3 2017, $32843.0 in Q4 2016, and $17436.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -1,129.00 |
| Sep 30, 2017 | -1,129.00 |
| Dec 31, 2016 | 32,843.00 |
| Dec 31, 2016 | 32,843.00 |
| Jun 30, 2016 | 17,436.00 |
| Jun 30, 2016 | 17,436.00 |
| Mar 31, 2016 | 12,747.00 |
| Mar 31, 2016 | 12,747.00 |
| Dec 31, 2015 | 5,895.00 |
| Dec 31, 2015 | 5,895.00 |
| Sep 30, 2015 | -8,823.00 |
| Sep 30, 2015 | -8,823.00 |
| Jun 30, 2015 | 12,957.00 |
| Jun 30, 2015 | 12,957.00 |
| Mar 31, 2015 | 57,283.00 |
| Mar 31, 2015 | 57,283.00 |
| Dec 31, 2014 | 40,319.00 |
| Dec 31, 2014 | 40,319.00 |
| Sep 30, 2014 | 60,534.00 |
| Sep 30, 2014 | 60,534.00 |